Circadian nuclear receptor Rev-erbalpha is expressed by platelets and potentiates platelet activation and thrombus formation
نویسندگان
چکیده
Abstract Background Adverse cardiovascular events have day/night patterns with peaks in the morning, potentially related to endogenous circadian clock control of platelet activation. Circadian nuclear receptor Rev-erbα is an essential and negative component clock. Purpose We aim investigate expression profile biological function platelets. Methods results Here we report presence functions human mouse Both showed a rhythm that positively correlated aggregation. Global knockout platelet-specific mice exhibited defective hemostasis as assessed by prolonged tail-bleeding times. deletion also reduced ferric chloride-induced carotid arterial occlusive thrombosis, prevented collagen/epinephrine-induced pulmonary thromboembolism, protected against microvascular microthrombi obstruction infarct expansion acute myocardial infarction model. In vitro thrombus formation CD41-labeled fluorescence intensity was significantly blood. Platelets from impaired agonist-induced aggregation responses, integrin αIIbβ3 activation α-granule release. Consistently, pharmacological inhibition specific antagonists decreased markers both Mechanistically, mass spectrometry co-immunoprecipitation analyses revealed potentiated via oligophrenin-1-mediated RhoA/ERM (ezrin/radixin/moesin) pathway. Conclusion provide first evidence protein functionally expressed platelets potentiates formation. may serve novel therapeutic target for managing thrombosis-based disease. Funding Acknowledgement Type funding sources: Foundation. Main source(s): This work supported grants National Science Fund Distinguished Young Scholars (81625002), Natural Foundation China (81930007).
منابع مشابه
Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock.
Lithium is commonly used to treat bipolar disorder, which is associated with altered circadian rhythm. Lithium is a potent inhibitor of glycogen synthase kinase 3 (GSK3), which regulates circadian rhythm in several organisms. In experiments with cultured cells, we show here that GSK3beta phosphorylates and stabilizes the orphan nuclear receptor Rev-erbalpha, a negative component of the circadia...
متن کاملThe prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation.
OBJECTIVE Low concentrations of prostaglandin (PG) E(2) enhance platelet aggregation, whereas high concentrations inhibit it. The effects of PGE(2) are mediated through 4 G protein-coupled receptors, termed E-type prostaglindin (EP) receptor EP1, EP2, EP3, and EP4. The platelet-stimulating effect of PGE(2) has been suggested to involve EP3 receptors. Here we analyzed the receptor usage relating...
متن کاملThe orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator.
Mammalian circadian rhythms are generated by a feedback loop in which BMAL1 and CLOCK, players of the positive limb, activate transcription of the cryptochrome and period genes, components of the negative limb. Bmal1 and Per transcription cycles display nearly opposite phases and are thus governed by different mechanisms. Here, we identify the orphan nuclear receptor REV-ERBalpha as the major r...
متن کاملOriginal Research: Focus on Platelets The Prostaglandin E2 Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation*
Objective—Low concentrations of prostaglandin (PG) E2 enhance platelet aggregation, whereas high concentrations inhibit it. The effects of PGE2 are mediated through 4 G protein-coupled receptors, termed E-type prostaglindin (EP) receptor EP1, EP2, EP3, and EP4. The platelet-stimulating effect of PGE2 has been suggested to involve EP3 receptors. Here we analyzed the receptor usage relating to th...
متن کاملNucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis.
BACKGROUND Pattern recognition receptor nucleotide-binding oligomerization domain 2 (NOD2) is well investigated in immunity, but its expression and function in platelets has never been explored. METHOD AND RESULTS Using reverse transcription polymerase chain reaction and Western blot, we show that both human and mouse platelets express NOD2, and its agonist muramyl dipeptide induced NOD2 acti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2022
ISSN: ['2634-3916']
DOI: https://doi.org/10.1093/eurheartj/ehac544.3035